Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant.

Libre C, Moro-Sibilot L, Giraud S, Martin L, Verhoeyen E, Costa C, Chebel A, Bissay N, Salles G, Genestier L, Sujobert P
Cancers (Basel). 2020 Apr 7;12(4). pii: cancers12040901. doi: 10.3390/cancers12040901. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.